| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―05 |
A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present) |
Václav Mik, Laila S. Benz, Jiří Voller, Theresia Dunzendorfer-Matt, Manfred S. Weiss, Vladimír Kryštof |
| 2 |
[GO] |
2021―Mar―09 |
Coronaviruses |
Claudiu T. Supuran |
| 3 |
[GO] |
2021―Feb―19 |
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents |
Austin N. Spratt, Fabio Gallazzi, Thomas P. Quinn, Christian L. Lorson, Anders Sönnerborg, Kamal Singh |
| 4 |
[GO] |
2021―Jan―21 |
SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19 |
Ilaria Vicenti, Maurizio Zazzi, Francesco Saladini |
| 5 |
[GO] |
2020―Dec―07 |
Repurposing drugs for the management of COVID-19 |
Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani, Mattia Mori |
| 6 |
[GO] |
2020―Nov―28 |
Protease inhibitors targeting the main protease and papain-like protease of coronaviruses |
Clemente Capasso, Alessio Nocentini, Claudiu T. Supuran |
| 7 |
[GO] |
2020―May―20 |
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review |
José Adão Carvalho Nascimento Junior, Anamaria Mendonça Santos, Lucindo José Quintans-Júnior, Cristiani Isabel Banderó Walker, Lysandro Pinto Borges, Mairim Russo Serafini |
| 8 |
[GO] |
2020―Apr―23 |
A deadly spillover: SARS-CoV-2 outbreak |
Mattia Mori, Clemente Capasso, Fabrizio Carta, William A Donald, Claudiu T Supuran |
